Filing Details
- Accession Number:
- 0001209191-18-062939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-17 16:24:16
- Reporting Period:
- 2018-12-13
- Accepted Time:
- 2018-12-17 16:24:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1169245 | Phasebio Pharmaceuticals Inc | PHAS | Pharmaceutical Preparations (2834) | 030375697 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755432 | James David Ballance | C/O Phasebio Pharmaceuticals, Inc. 1 Great Valley Parkway, Suite 30 Malvern PA 19355 | Vp, Research And Sci. Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-13 | 1,000 | $3.94 | 7,600 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
